Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
799天前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1065天前
Canadian Market Advances; Cameco, Celestica Up Sharply
The Canadian market is up in positive territory around late morning on Tuesday thanks to gains in technology stocks. Energy stocks are weak, weighed down by a sharp drop in crude oil prices.
RTTNews
|
1小時46分鐘前
U.S. Consumer Confidence Edges Modestly Lower In October
Consumer confidence in the U.S. saw a modest deterioration in the month of October, according to a report released by the Conference Board on Tuesday. The Conference Board said its consumer confidence index dipped to 94.6 in October from an upwardly revised 95.6 in September.
RTTNews
|
3小時11分鐘前
PayPal Lifts FY25 Outlook Above Market, Teams With OpenAI; Stock Up
Shares of PayPal Holdings, Inc. were gaining around 15 percent in the pre-market activity on the Nasdaq, after the company issued earnings forecast for its fourth quarter expecting year-over-year growth, and raised fiscal 2025 outlook above the market estimates. The payment technology major also initiated quarterly cash dividend after reporting higher third-quarter results above market.
RTTNews
|
4小時27分鐘前
Falling Commodity Prices Likely To Weigh On Canadian Market At Open
Canadian market is likely to open on a negative note Tuesday morning, weighed down by falling crude oil and gold prices.
The mood is likely to remain cautious ahead of the monetary policy announcements from the Bank of Canada and the Federal Reserve on Wednesday.
RTTNews
|
4小時52分鐘前
German GfK Consumer Sentiment To Continue Falling On Weak Income Expectations
German consumer confidence is likely to continue its downward trend in November on weaker income expectations, monthly survey data published jointly by NIQ/GfK and the Nuremberg Institute for Market Decisions showed Tuesday. The forward-looking consumer climate indicator fell unexpectedly to -24.1 in November from revised -22.5 in October. The score was expected to improve to -22.0.
RTTNews
|
5小時44分鐘前
UPS Sees Q4 Revenues Above Street As Q3 Beats Market, Despite A Fall; Stock Gains
Shares of United Parcel Service Inc. were gaining around 9 percent in the pre-market activity on Tuesday after the logistics major issued fourth-quarter outlook for revenues above market estimates after the third-quarter adjusted earnings and top line beat the Street. On a reported basis, third-quarter earnings were down mainly as revenues were hit by weak results in U.S. Domestic and Supply Chain
RTTNews
|
6小時1分鐘前
